,i #aafth ,,congress #ast ,session ,h4 ,r4 #cjbi ,,in ,,the ,,house ,,of ,,representatives ,may #bh1 #bjai,mr4 ,olson 7for himself1 ,ms4 ,barragn1 ,mr4 ,marchant1 and ,mr4 ,lewis7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to provide transitional coverage and retroactive ,medicare part ,d coverage for certain low-income beneficiaries4 #a4 ,short title ,this ,act may be cited as the ,improving ,low-,income ,access to ,prescription ,drugs ,act of #bjai4 #b4 ,transitional coverage and retroactive ,medicare part ,d coverage for certain low-income beneficiaries ,section #ahfj;,d-#ad of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aad7 is amended-- 7#a7 by redesignating subsection 7e7 as subsection 7f72 and 7#b7 by adding after subsection 7d7 the following new subsection3 7e7 ,limited income newly eligible transition program 7#a7 ,in general ,the ,secretary shall carry out a program to provide transitional coverage for covered part ,d drugs for ,,li ,,net eligible individuals in accordance with this subsection4 7#b7 ,,li net eligible individual defined ,for purposes of this subsection1 the term ,,li ,,net eligible individual means a part ,d eligible individual who-- 7,a7 is a subsidy eligible individual2 and 7,b7 has not yet enrolled in a prescription drug plan or an ,,ma-,,pd plan1 or1 who has so enrolled1 but with respect to whom coverage under such plan has not yet taken effect4 7#c7 ,transitional coverage ,for purposes of this subsection1 the term transitional coverage means with respect to an ,,li ,,net eligible individual-- 7,a7 immediate access to covered part ,d drugs at the point of sale during the period that begins on the first day of the month such individual is determined to be a subsidy eligible individual and ends on the date that coverage under a prescription drug plan or ,,ma-,,pd plan takes effect with respect to such individual2 and 7,b7 in the case of an ,,li ,,net eligible individual who is a full-benefit dual eligible individual 7as defined in section #aice7;c77#f77 or a recipient of supplemental security income benefits under title ,,xvi1 retroactive coverage 7in the form of reimbursement of the amounts that would have been paid under this part had such individual been enrolled in a prescription drug plan or ,,ma-,,pd plan7 of covered part ,d drugs purchased by such individual during the period that begins on the date that is the later of-- 7i7 the date that such individual was first eligible for a low-income subsidy under this part2 or 7ii7 the date that is #cf months prior to the date such individual enrolls in a prescription drug plan or ,,ma-,,pd plan1 and ends on the date that coverage under such plan takes effect4 7#d7 ,program administration 7,a7 ,single point of contact ,the ,secretary shall1 to the extent feasible1 administer the program under this subsection through a contract with a single program administrator4 7,b7 ,benefit design ,the ,secretary shall ensure that the transitional coverage provided to ,,li ,,net eligible individuals under this subsection-- 7i7 provides access to all covered part ,d drugs under an open formulary2 7ii7 permits all pharmacies determined by the ,secretary to be in good standing to process claims under the program2 7iii7 is consistent with such requirements as the ,secretary considers necessary to improve patient safety and ensure appropriate dispensing of medication2 and 7iv7 meets such other requirements as the ,secretary may establish4 7#e7 ,relationship to other provisions of this title2 waiver authority 7,a7 ,in general ,the following provisions shall not apply with respect to the program under this subsection3 7i7 ,paragraphs 7#a7 and 7#c77;,b7 of section #ahfj;,d-#d7;a7 7relating to dissemination of general information2 availability of information on changes in formulary through the internet74 7ii7 ,subparagraphs 7,a7 and 7,b7 of section #ahfj;,d-#d7;b77#c7 7relating to requirements on development and application of formularies2 formulary development74 7iii7 ,paragraphs 7#a77;,c7 and 7#b7 of section #ahfj;,d-#d7;c7 7relating to medication therapy management program74 7,b7 ,waiver authority ,the ,secretary may waive such other requirements of titles ,,xi and this title as may be necessary to carry out the purposes of the program established under this subsection4 4